Aktiesnakken — Oktober 2010
-
ja
-
....... GSK coming up -------
-
wassååå!?
-
musak....
-
varnæs dont be gloomy. Du har lige fået validere den indikation til +1 mia værdi i genmab...
-
jeg har set fødslen af et nicheprodukt, hvis ikke de får røven i gear
-
så starter vitty....
-
og så kommer julian.
-
vi får 16 pence i dividende
-
price cuts og health reform i US og europ
-
og det har en effekt på 140 M Pund alene i det her kvartal
-
når man renser for pandemic salg, avandia og generisk konkurrence så har de god vækst nedenunder
-
Emerging markets igen, Vaccine god, Good start in US med vores nye oncology products!!
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind